{
  "id": 20555545,
  "title": "Yicura BioMed eyes IPO as CEO says Hong Kong biotech scene needs more patient capital",
  "url": "https://urgent.news/2026/11/18/yicura-biomed-eyes-ipo-as-ceo-says-hong-kong-biotech-scene-needs-more-20555545",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-18T06:00:08.000Z",
  "source": {
    "name": "South China Morning Post",
    "slug": "south-china-morning-post",
    "url": "https://www.scmp.com/business/companies/article/3374843/yicura-biomed-eyes-ipo-ceo-says-hong-kong-biotech-scene-needs-more-patient-capital"
  },
  "original_language": "en",
  "account": null,
  "summary": "Hong Kong needs more “patient capital” and more talent capable of commercialising research and development to sustain the city’s biotechnology ecosystem, according to a senior executive at a local biotech start-up. Yicura BioMed, based in the Hong Kong Science Park, is heading towards an initial public offering (IPO) in the city as soon as practicable, CEO Xian Jin said in an interview. “Biotech…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CoinDesk",
        "title": "Hong Kong, Swift test tokenized deposits as banks chase stablecoin-style speed",
        "url": "https://urgent.news/2026/11/17/hong-kong-swift-test-tokenized-deposits-as-banks-chase-stablecoin",
        "published": "2026-11-17T15:11:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}